References
- Mukhopadhyay C, Shaw T, Varghese GM, et al. Melioidosis in South Asia (India, Nepal, Pakistan, Bhutan and Afghanistan). Trop Med Infect Dis. 2018 May 22;3(2):51. doi:https://doi.org/10.3390/tropicalmed3020051
- Chin CY, Monack DM, Nathan S. Genome wide transcriptome profiling of a murine acute melioidosis model reveals new insights into how Burkholderia pseudomallei overcomes host innate immunity. BMC Genom. 2010 Nov 27;11:672. doi:https://doi.org/10.1186/1471-2164-11-672
- Wiersinga WJ, Virk HS, Torres AG, et al. Melioidosis [Review]. Nat Rev Dis Prim. 2018 Feb 1;4:17107. doi:https://doi.org/10.1038/nrdp.2017.107
- Cheng AC, Dance DA, Currie BJ. Bioterrorism, glanders and melioidosis. Euro Surveill. 2005 Mar;10(3):11–12. doi:https://doi.org/10.2807/esm.10.03.00528-en
- Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev. 2005 Apr;18(2):383–416. doi:https://doi.org/10.1128/CMR.18.2.383-416.2005
- Conejero L, Potempa K, Graham CM, et al. The blood transcriptome of experimental melioidosis reflects disease severity and shows considerable similarity with the human disease. J Immunol. 2015 Oct 1;195(7):3248–3261. doi:https://doi.org/10.4049/jimmunol.1500641
- Clark GC, Essex-Lopresti A, Moore KA, et al. Common host responses in murine aerosol models of infection caused by highly virulent gram-negative bacteria from the Genera Burkholderia, Francisella and Yersinia. Pathogens. 2019 Sep 21;8(4):159. doi:https://doi.org/10.3390/pathogens8040159
- Dunachie SJ, Jenjaroen K, Reynolds CJ, et al. Infection with Burkholderia pseudomallei - immune correlates of survival in acute melioidosis. Sci Rep. 2017 Sep 22;7(1):12143. doi:https://doi.org/10.1038/s41598-017-12331-5
- Pankla R, Buddhisa S, Berry M, et al. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol. 2009;10(11):R127. doi:https://doi.org/10.1186/gb-2009-10-11-r127
- Krishnananthasivam S, Jayathilaka N, Sathkumara HD, et al. Host gene expression analysis in Sri Lankan melioidosis patients. PLoS Negl Trop Dis. 2017 Jun;11(6):e0005643. doi:https://doi.org/10.1371/journal.pntd.0005643
- Chaussabel D, Pascual V, Banchereau J. Assessing the human immune system through blood transcriptomics. BMC Biol. 2010 Jul 1;8:84. doi:https://doi.org/10.1186/1741-7007-8-84
- Kaewarpai T, Ekchariyawat P, Phunpang R, et al. Longitudinal profiling of plasma cytokines in melioidosis and their association with mortality: a prospective cohort study. Clin Microbiol Infect. 2020 Jun;26(6):783.e1–783.e8. doi:https://doi.org/10.1016/j.cmi.2019.10.032.
- Duval BD, Elrod MG, Gee JE, et al. Evaluation of a latex agglutination assay for the identification of Burkholderia pseudomallei and Burkholderia mallei. Am J Trop Med Hyg. 2014 Jun;90(6):1043–1046. doi:https://doi.org/10.4269/ajtmh.14-0025
- Suttisunhakul V, Pumpuang A, Ekchariyawat P, et al. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the identification of Burkholderia pseudomallei from Asia and Australia and differentiation between Burkholderia species. PLoS One. 2017;12(4):e0175294. doi:https://doi.org/10.1371/journal.pone.0175294
- Wright SW, Kaewarpai T, Lovelace-Macon L, et al. A two biomarker model augments clinical prediction of mortality in melioidosis. Clin Infect Dis. 2020 Feb 8:ciaa126. doi:https://doi.org/10.1093/cid/ciaa126
- Cliff JM, Cho JE, Lee JS, et al. Excessive cytolytic responses predict tuberculosis relapse after apparently successful treatment. J Infect Dis. 2016 Feb 1;213(3):485–495. doi:https://doi.org/10.1093/infdis/jiv447
- Breiman L. Random forests. Mach Learn. 2001 October;45:5–32. doi:https://doi.org/10.1023/A:1010933404324
- Lang Y, Jiang Y, Gao M, et al. Interleukin-1 receptor 2: a new biomarker for sepsis diagnosis and Gram-negative/Gram-positive bacterial differentiation. Shock. 2017 Jan;47(1):119–124. doi:https://doi.org/10.1097/SHK.0000000000000714
- Pino-Yanes M, Ma SF, Sun X, et al. Interleukin-1 receptor-associated kinase 3 gene associates with susceptibility to acute lung injury. Am J Respir Cell Mol Biol. 2011 Oct;45(4):740–745. doi:https://doi.org/10.1165/rcmb.2010-0292OC
- Wiersinga WJ, van't Veer C, van den Pangaart PS, et al. Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis). Crit Care Med. 2009 Feb;37(2):569–576. doi:https://doi.org/10.1097/CCM.0b013e318194b1bf
- Wang S, Song R, Wang Z, et al. S100a8/A9 in inflammation. Front Immunol. 2018;9:1298. doi:https://doi.org/10.3389/fimmu.2018.01298
- Schenten V, Plancon S, Jung N, et al. Secretion of the phosphorylated form of S100A9 from neutrophils is essential for the proinflammatory functions of extracellular S100A8/A9. Front Immunol. 2018 Mar 13;9:447. doi:https://doi.org/10.3389/fimmu.2018.00447
- Leanderson T, Liberg D, Ivars F. S100a9 as a pharmacological target molecule in inflammation and cancer. Endocr Metab Immune Disord Drug Targets. 2015;15(2):97–104. doi:https://doi.org/10.2174/1871530315666150316123854
- Zhang GL, Zou YF, Feng XL, et al. Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: a meta-analysis. Inflamm Res. 2011 Jan;60(1):11–18. doi:https://doi.org/10.1007/s00011-010-0216-2
- Ali S, Hirschfeld AF, Mayer ML, et al. Functional genetic variation in NFKBIA and susceptibility to childhood asthma, bronchiolitis, and bronchopulmonary dysplasia. J Immunol. 2013 Apr 15;190(8):3949–3958. doi:https://doi.org/10.4049/jimmunol.1201015
- von Bernuth H, Puel A, Ku CL, et al. Septicemia without sepsis: inherited disorders of nuclear factor-kappa B-mediated inflammation. Clin Infect Dis. 2005 Nov 15;41(Suppl 7):S436–S439. doi:https://doi.org/10.1086/431994
- Peng D, Pang F, Cao R, et al. Upregulation of immune process-associated genes in RAW264.7 Macrophage cells in response to Burkholderia pseudomallei infection. Biomed Res Int. 2018 Jun 4;2018:1235097. doi:https://doi.org/10.1155/2018/1235097
- Pachot A, Monneret G, Brion A, et al. Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med. 2005 Jan;33(1):31–38. discussion 236-7. doi:https://doi.org/10.1097/01.CCM.0000150958.20209.A3
- Lekkou A, Karakantza M, Mouzaki A, et al. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol. 2004 Jan;11(1):161–167. doi:https://doi.org/10.1128/CDLI.11.1.161-167.2004
- Zhuang Y, Peng H, Chen Y, et al. Dynamic monitoring of monocyte HLA-DR expression for the diagnosis, prognosis, and prediction of sepsis. Front Biosci (Landmark Ed. 2017 Mar 1;22:1344–1354. doi:https://doi.org/10.2741/4547
- Holling TM, van der Stoep N, Quinten E, et al. Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III. J Immunol. 2002 Jan 15;168(2):763–770. doi:https://doi.org/10.4049/jimmunol.168.2.763
- Poluektov YO, Kim A, Sadegh-Nasseri S. HLA-DO and its role in MHC class II antigen presentation. Front Immunol. 2013 Aug 29;4:260. doi:https://doi.org/10.3389/fimmu.2013.00260
- West TE, Ernst RK, Jansson-Hutson MJ, et al. Activation of toll-like receptors by Burkholderia pseudomallei. BMC Immunol. 2008 Aug 8;9(46). doi:https://doi.org/10.1186/1471-2172-9-46
- Wiersinga WJ, Wieland CW, Dessing MC, et al. Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis). PLoS Med. 2007 Jul 31;4(7):e248. doi:https://doi.org/10.1371/journal.pmed.0040248
- Chantratita N, Tandhavanant S, Myers ND, et al. Screen of whole blood responses to flagellin identifies TLR5 variation associated with outcome in melioidosis. Genes Immun. 2014 Mar;15(2):63–71. doi:https://doi.org/10.1038/gene.2013.60
- Sengyee S, Yoon SH, Paksanont S, et al. Comprehensive analysis of clinical Burkholderia pseudomallei isolates demonstrates conservation of unique lipid A structure and TLR4-dependent innate immune activation. PLoS Negl Trop Dis. 2018 Feb;12(2):e0006287. doi:https://doi.org/10.1371/journal.pntd.0006287
- Hii CS, Sun GW, Goh JW, et al. Interleukin-8 induction by Burkholderia pseudomallei can occur without Toll-like receptor signaling but requires a functional type III secretion system. J Infect Dis. 2008 Jun 1;197(11):1537–1547. doi:https://doi.org/10.1086/587905
- Kang WT, Vellasamy KM, Vadivelu J. Eukaryotic pathways targeted by the type III secretion system effector protein, BipC, involved in the intracellular lifecycle of Burkholderia pseudomallei. Sci Rep. 2016 Sep 16;6:33528. doi:https://doi.org/10.1038/srep33528
- Ng MY, Wang M, Casey PJ, et al. Activation of MAPK/ERK signaling by Burkholderia pseudomallei cycle inhibiting factor (Cif). PLoS One. 2017 Feb 612(2):e0171464. doi:https://doi.org/10.1371/journal.pone.0171464
- Krishnananthasivam S, Sathkumara HD, Corea E, et al. Gene expression profile of Human Cytokines in response to Burkholderia pseudomallei infection. mSphere. 2017 Apr 19;2(2):e00121-17. doi:https://doi.org/10.1128/mSphere.00121-17